Patents
More topics under "C07D - Heterocyclic compounds" (1,537,440)
C07D 201 - Preparation, separation, purification, or stabilisation of unsubstituted lactams (2,192)
C07D 203 - Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom (1,097)
C07D 205 - Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom (6,868)
C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676)
C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems (11,865)
C07D 219 - Heterocyclic compounds containing acridine or hydrogenated acridine ring systems (2,120)
C07D 221 - Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups (10,931)
C07D 223 - Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom (8,732)
C07D 225 - Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom (1,649)
C07D 227 - Heterocyclic compounds containing rings having one nitrogen atom as the only ring hetero atom, according to more than one of groups (473)
C07D 229 - Heterocyclic compounds containing rings of less than five members having two nitrogen atoms as the only ring hetero atoms (515)
C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550)
C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings (15,325)
C07D 237 - Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings (8,468)
C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673)
C07D 243 - Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms (5,961)
C07D 245 - Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms (898)
C07D 247 - Heterocyclic compounds containing rings having two nitrogen atoms as the only ring hetero atoms, according to more than one of groups (239)
C07D 249 - Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms (17,749)
C07D 251 - Heterocyclic compounds containing 1,3,5-triazine rings (10,913)
C07D 253 - Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group (2,967)
C07D 255 - Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups (739)
C07D 257 - Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms (9,612)
C07D 259 - Heterocyclic compounds containing rings having more than four nitrogen atoms as the only ring hetero atoms (488)
C07D 261 - Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings (11,459)
C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978)
C07D 265 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms (11,132)
C07D 267 - Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms (2,022)
C07D 269 - Heterocyclic compounds containing rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms according to more than one of groups (111)
C07D 271 - Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms (7,144)
C07D 273 - Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups (2,368)
C07D 275 - Heterocyclic compounds containing 1, 2-thiazole or hydrogenated 1,2-thiazole rings (4,972)
C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621)
C07D 279 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms (5,149)
C07D 281 - Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms (1,924)
C07D 283 - Heterocyclic compounds containing rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms, according to more than one of groups (102)
C07D 285 - Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups (9,964)
C07D 291 - Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms (1,087)
C07D 293 - Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms (553)
C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
C07D 301 - Preparation of oxiranes (10,136)
C07D 303 - Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom (12,512)
C07D 305 - Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms (5,442)
C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
C07D 309 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings (12,815)
C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127)
C07D 313 - Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom (3,580)
C07D 315 - Heterocyclic compounds containing rings having one oxygen atom as the only ring hetero atom according to more than one of groups (1,360)
C07D 317 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms (18,224)
C07D 319 - Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms (10,283)
C07D 321 - Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups (2,079)
C07D 323 - Heterocyclic compounds containing more than two oxygen atoms as the only ring hetero atoms (1,581)
C07D 325 - Heterocyclic compounds containing rings having oxygen as the only ring hetero atom according to more than one of groups (168)
C07D 327 - Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms (2,428)
C07D 329 - Heterocyclic compounds containing rings having oxygen and selenium or oxygen and tellurium atoms as the only ring hetero atoms (47)
C07D 331 - Heterocyclic compounds containing rings of less than five members, having one sulfur atom as the only ring hetero atom (456)
C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883)
C07D 335 - Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom (4,725)
C07D 337 - Heterocyclic compounds containing rings of more than six members having one sulfur atom as the only ring hetero atom (875)
C07D 339 - Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms (3,352)
C07D 341 - Heterocyclic compounds containing rings having three or more sulfur atoms as the only ring hetero atoms (281)
C07D 343 - Heterocyclic compounds containing rings having sulfur and selenium or sulfur and tellurium atoms as the only ring hetero atoms (52)
C07D 345 - Heterocyclic compounds containing rings having selenium or tellurium atoms as the only ring hetero atoms (419)
C07D 347 - Heterocyclic compounds containing rings having halogen atoms as ring hetero atoms (38)
C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group (11,963)
C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
C07D 411 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms (2,465)
C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
C07D 415 - Heterocyclic compounds containing the thiamine skeleton (90)
C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
C07D 419 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms (1,431)
C07D 421 - Heterocyclic compounds containing two or more hetero rings, at least one ring having selenium, tellurium, or halogen atoms as ring hetero atoms (480)
C07D 451 - Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.02,4] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof (5,273)
C07D 453 - Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids (5,704)
C07D 455 - Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine (2,122)
C07D 457 - Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula: , e.g. lysergic acid (836)
C07D 459 - Heterocyclic compounds containing benz [g] indolo [2, 3-a] quinolizine ring systems, e.g. yohimbine; 16, 18-lactones thereof, e.g. reserpic acid lactone (97)
C07D 461 - Heterocyclic compounds containing indolo [3, 2, 1-d, e] pyrido [3, 2, 1-i, j] [1, 5]-naphthyridine ring systems, e.g. vincamine (286)
C07D 463 - Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (613)
C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
C07D 473 - Heterocyclic compounds containing purine ring systems (11,932)
C07D 475 - Heterocyclic compounds containing pteridine ring systems (2,718)
C07D 477 - Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (2,484)
C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
C07D 489 - Heterocyclic compounds containing 4ah-8, 9 c- iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: (2,334)
C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
C07D 493 - Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system (17,376)
C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336)
C07D 497 - Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms (1,069)
C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960)
C07D 499 - Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (3,448)
C07D 501 - Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (7,574)
C07D 503 - Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (648)
C07D 505 - Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (556)
C07D 507 - Heterocyclic compounds containing a condensed beta-lactam ring system, not provided for by groups , or; Such ring systems being further condensed (161)
C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (15,120)
C07D 515 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (877)
C07D 517 - Heterocyclic compounds containing in the condensed system at least one hetero ring having selenium, tellurium, or halogen atoms as ring hetero atoms (452)
C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or (11,041)
C07D 521 - Heterocyclic compounds containing unspecified hetero rings (16,203)
Patents for C07D - Heterocyclic compounds (10,420)
03/1995
03/15/1995EP0642782A2 Shampoo-conditioner composition
03/15/1995EP0642513A1 Indolocarbazole imides and their use
03/15/1995EP0248876B1 Process for the preparation of 1-methylamino-quinoline-carboxylic acid derivatives
03/15/1995CN1027892C Improved process for preparation of substituted indolone derivatives
03/08/1995EP0641795A1 Carbapenem derivative
03/08/1995EP0565546B1 (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]-hydrazono]propanedinitrile
03/01/1995EP0547090B1 Phenolic thioetheramides as 5-lipoxygenase inhibitors
03/01/1995CN1099392A Compounds containing a fused bicyclic ring and processes therefor
03/01/1995CA2131037A1 Shampoo-conditioner composition
02/1995
02/28/1995US5393760 Guanidine derivatives
02/23/1995WO1995005366A1 Vasoconstrictive substituted aryloxyalkyl diamines
02/22/1995EP0639577A1 Phosphonooxymethyl or methylthiomethyl ethers of taxane derivatives as antitumor agents
02/22/1995EP0639186A1 Taxol derivatives
02/22/1995CN1099030A Biocidal compounds
02/21/1995USRE34865 Antibiotics
02/21/1995US5391742 2-(8-Azabicyclo(3.2.1)oct-8-yl)alkanols
02/19/1995CA2117503A1 Azoxycyanobenzodioxane derivatives
02/16/1995WO1995004726A1 Arthropodicidal oxazolines and thiazolines
02/15/1995EP0638068A1 Process for the manufacture of (s)-3-amino-1-substituted-pyrrolidines
02/15/1995EP0637960A1 SUBSTITUTED INDOLIZINO 1,2-b]QUINOLINONES
02/14/1995US5389626 3-aryloxmethyl-cephalosporin derivatives, and their medical use
02/14/1995US5389290 Ferroelectric liquid crystalline materials
02/07/1995US5387681 Synthesis of bicyclic aromatic sulfonic acids sulfonyl chlorides and sulfonamides
02/07/1995US5387585 Treating epilepsy, anxiety, sleep disorders, schizophrnia, senile dementia
02/01/1995EP0636625A2 Tricyclic diazepine vasopressin antagonists and oxytocin antagonists
02/01/1995EP0636623A1 Indole derivatives as 5-HT1- like agonists
02/01/1995EP0556308B1 Oxysulfonyl urea acat inhibitors
02/01/1995EP0549594B1 (2-imidazolin-2-ylamino) quinoxaline derivatives and methods for using same
02/01/1995CN1098095A Salt of (S)-a-phenyl-2-pyridineethanamine useful in therapy
02/01/1995CN1098094A Aryl substituted heterocycles
01/1995
01/26/1995WO1995002591A1 Tri-substituted imidazoles having multiple therapeutic properties
01/26/1995CA2167311A1 Tri-substituted imidazoles having multiple therapeutic properties
01/25/1995CN1097758A Pyrrolopyrimidines
01/25/1995CN1097746A C10 taxane derivatives and pharmaceutical compositions containing them
01/25/1995CN1097736A Novel antiarrhythmic agents I
01/24/1995US5384399 Oxazinone compounds for the preparation of taxol
01/19/1995WO1995001979A1 Novel (1-heteroazolyl-1-heterocyclyl)alkane derivatives and their use as neuroprotective agents
01/19/1995WO1995001977A1 Magnesium omeprazole
01/19/1995WO1995001966A1 Iodinated oligomeric compounds and diagnostic compositions containing the same
01/19/1995CA2164856A1 Novel (1-heteroazolyl-1-heterocyclyl) alkane derivatives and their use as neuroprotective agents
01/18/1995EP0633879A1 Enantiomeric 1-phenyl-2-(2-pyridinyl)ethylamine for the treatment of neurodegenerative disorders
01/17/1995US5382594 Cognition activators
01/11/1995EP0633259A1 Sulfonylaminopyrimidines, their preparation and their use as medicine
01/11/1995EP0544696B1 Hypoglycemic hydroxyurea derivatives
01/10/1995US5380851 2-amino-5-cyano-1,4-dihydropyridines, processes for their preparation
01/10/1995US5380731 Piperidinyl benzimidazoles as antagonist of histamine H1
01/10/1995EP0639186A4 Taxol derivatives.
01/05/1995WO1995000480A1 Novel intermediates for the preparation of antihistaminic 4-diphenylmethyl/diphenylmethoxy piperidine derivatives
01/03/1995US5378712 Antithrombosis
12/1994
12/28/1994EP0630887A1 4-(aryl-substituted)-piperidines as neurokinin receptor antagonists
12/22/1994WO1994029301A1 Stereoselective synthesis of nucleoside analogues using bicyclic intermediate
12/22/1994WO1994029274A1 New active compounds
12/22/1994CA2164875A1 New active compounds
12/21/1994EP0629627A2 Bicyclic carboxylic acids and their derivatives as nep and aca inhibitors
12/21/1994EP0629616A2 Optically aktive 2-imidazolin-5-one and 2-imidazolin-5-thione derivatives as fungicides
12/20/1994US5374649 Indole derivatives and pharmaceutical use thereof
12/20/1994US5374648 Nervous system disorders
12/20/1994US5374416 Diagnostic,therapeutic agent for nuclear magnetic resonance, radiology
12/14/1994EP0628038A1 3-ALKYLOXY-, ARYLOXY-, OR ARYLALKYLOXYBENZO b]THIOPHENE-2-CARBOXAMIDES AS INHIBITORS OF CELL ADHESION
12/14/1994EP0565558B1 Process and intermediates for preparing azabicyclo 2.2.2]octan-3-imines
12/14/1994CN1096157A Fungicidal oxazolidinones
12/13/1994US5373018 Antagonist to excitory amino acids on N-methyl aspartic acid receptor complex, theraputically effective in treatment of central nervous system disorder
12/08/1994WO1994027988A1 Optically pure salts of pyridinylmethyl sulfinyl-ih-benzimidazole compounds
12/08/1994CA2337581A1 Optically pure salts of pyridinylmethyl sulfinyl-1h-benzimidazole compounds and intermediates in the preparation therefor
12/07/1994EP0626953A1 Novel sidechain-bearing taxanes and intermediates thereof
12/07/1994EP0626939A1 Tri-substituted phenyl derivatives as phosphodiesterase inhibitors
11/1994
11/30/1994EP0625969A1 Arylalkoxyphenoxy-imidazoline compounds
11/30/1994CN1026788C Triazole antifungal agents
11/25/1994CA2124048A1 Aryl substituted heterocycles
11/22/1994US5366982 Substituted bicyclic bis-aryl compounds exhibiting selective leukotriene B4 antagonist activity, their preparation and use in pharmaceutical compositions
11/16/1994CN1095069A Novel process
11/16/1994CN1095066A Herbicides
11/15/1994US5364882 Acyloenzyme a: cholesterol acyltransferase inhibitors, anticholesterol
11/15/1994US5364866 Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analetics
11/10/1994WO1994025466A1 Water soluble derivatives of camptothecin and their use as antitumor agents
11/10/1994CA2161681A1 Water soluble derivatives of camptothecin and their use as antitumor agents
11/09/1994EP0570401B1 Lipoxygenase-inhibiting hydroxamic acid and n-hydroxyurea derivatives
11/09/1994EP0533824B1 Piperidyl-substituted indoles
11/09/1994EP0532527B1 3-amino-2-aryl quinuclidines, process for their preparation and pharmaceutical compositions containing them
11/09/1994CN1094725A Methods for the preparation of novel sidechain-bearing taxanes and intermediates thereof
11/01/1994US5360817 Derivatives and analogues of 2-deoxy-2,3-didehydro-N-acetyl neuraminic acid and their use as antiviral agents
10/1994
10/31/1994CA2122178A1 Biocidal compounds
10/26/1994CN1094038A Amino-substituted pyrazoles
10/25/1994US5359058 A cephalosporin compound substituted in the 7-position with a (cyclo)alkylideneammonio group
10/25/1994US5358948 Psychological, nervous system disorders
10/25/1994CA1332735C 20, 21-dinoreburnamenine substituted derivatives, preparation process thereof and new intermediates so obtained, their application as drugs, and pharmaceutical compositions containing them
10/19/1994CN1093704A Regioselective synthesis of 4-chloro-2-thiophenecarboxylic acid
10/18/1994US5356926 Antiinflammatory agents
10/13/1994WO1994022831A1 (s)-alpha-phenyl-2-pyridineethanamine (s)-malate and its use as a medicament
10/12/1994EP0618906A1 Substituted imidazole derivatives and their preparation and use
10/12/1994CN1093357A Novel selective aromatase inhibiting compounds
10/05/1994EP0533695B1 IMIDAZO (4,5-c) PYRIDINES WITH PAF ANTAGONIST ACTIVITY
10/04/1994US5352806 Anticarcinogenic agents
09/1994
09/28/1994CN1092776A 2-(9-fluorenonyl)-carbapenem intermediates
09/21/1994CN1092416A Taxanes having a butenyl substituted side-chain and pharmaceutical compositions containing them
09/21/1994CN1092413A Tropone-substituted phenyloxazolidinone antibacterial agents
09/20/1994CA1332060C Arylpyrrole insecticidal acaricidal and nematicidal agents and method for the preparation thereof
09/14/1994EP0571485B1 3-substituted 1,2,3,4-oxatriazole-5-imine compounds, a process for the preparation thereof and a pharmaceutical preparation containing said compounds
09/14/1994CN1092064A Tri-substituted phenyl derivatives and processes for their preparation
09/13/1994US5346691 For use in dermatological and cosmetic compositions
1 ... 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 ... 105